Ovarian Cancer: the Not-so-silent Killer

Key points
- Ovarian cancer doesn’t get the kind of attention breast cancer gets.
- First, researchers recently reported a cluster of symptoms that can indicate ovarian cancer.
- September is Ovarian Cancer Awareness Month, and advocates are waving the teal flag, teal being the ovarian cancer version of a pink ribbon.
- Bloating, pelvic or abdominal pain, difficulty eating, feeling full quickly, and frequent or urgent urinating are shown to be more common in women with ovarian cancer.
Ovarian cancer doesn’t get the kind of attention breast cancer gets. It’s not as common, and because survival rates are poor, it does not produce an army of survivors to raise awareness. It’s traditionally known as the “silent killer” because it was thought to reveal no symptoms in its earliest, most curable stages.
But ovarian cancer is silent no more. First, researchers recently reported a cluster of symptoms that can indicate ovarian cancer. And advocates – both survivors and families – are beginning to make noise and encourage awareness for this disease.
September is Ovarian Cancer Awareness Month, and advocates are waving the teal flag, teal being the ovarian cancer version of a pink ribbon. Advocates and researchers at the University of Michigan Comprehensive Cancer Center hope to get people talking about ovarian cancer. What’s there to say? Start with these eight things you need to know:
1. Symptoms do exist. Bloating, pelvic or abdominal pain, difficulty eating, feeling full quickly, and frequent or urgent urinating are shown to be more common in women with ovarian cancer. These are vague symptoms and often mistaken for gastrointestinal problems. But if they persist for several days, get checked out by your gynecologist. “You can explain away these symptoms to yourself. But the only way to be sure it’s nothing is to go get a pelvic exam,” says J. Rebecca Liu, M.D., assistant professor of obstetrics and gynecology at the U-M Medical School and a gynecologic oncologist at the U-M Comprehensive Cancer Center.
2. There is no screening test for ovarian cancer, like a Pap smear or mammogram. The CA125 blood test measures the amount of a certain protein that’s often elevated with ovarian cancer. But the test is not foolproof. “There are a lot of benign conditions that can cause higher levels of CA125,” Liu says. Early detection is a key area of research. U-M researchers are looking for markers in the blood that indicate ovarian cancer, an approach that could in time lead to a blood test to screen for ovarian cancer.
3. All women need yearly pelvic exams. Maybe your doctor says you don’t need a Pap smear every year, but Pap tests just check for cervical abnormalities. A pelvic exam is not the same thing. In particular, older women should not discontinue their yearly gynecology visit as ovarian cancer is more likely to occur in women older than 60. “A pelvic exam is key because it’s the best screening we have right now,” Liu says.
4. Survival rates are significantly better when ovarian cancer is diagnosed in an early stage. With stage I ovarian cancer, the earliest stage, 95 percent of women are alive five years after diagnosis. Only 30 percent of women with stage III or IV ovarian cancer survive five years. More than 22,000 women will be diagnosed with ovarian cancer this year and more than 15,000 will die from the disease. Some 70 percent of women have advanced disease when they are diagnosed.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsResearch backs risk-reduction surgery for ovarian cancer
A study by Manchester scientists backs preventative surgery to improve survival for women who are at greater risk of getting ovarian cancer and suggests it appears helpful for women at risk of getting breast cancer…
18 December 2013
NewsSurviving Ovarian Cancer: Rutgers Scientists Attack Drug Resistant Cancer Cells
Scientists at Rutgers University have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates for the most deadly gynecological cancer in the…
10 December 2013
NewsKiller cocktail fights brain cancer
A novel immune-boosting drug combination eradicates brain cancer in mice, according to a study in The Journal of Experimental Medicine. Glioblastoma is the most aggressive form of brain cancer, and current treatments…
26 November 2013


